They surely take note of the Opsens potential..
Un super gros dont les ventes sont pres de $ 5.5 Billion
Tavar sales forecast $ 3,5 to $ 3,7 Billion
Nombre d,actions en circulation 628 000 000
Fermeture vendredi US $ 93,35
On se met a rever que Edwards Lifesciences fasse une offre d’achat disons dans 1 an et qui sait peut etre a
$ 5 ou $ 6
Edwards Lifeciences
Second Quarter Highlights and Outlook
- Q2 sales of $1.37 billion were flat versus an elevated prior year; underlying1 sales grew 5 percent
- Q2 TAVR sales grew 1 percent; underlying 5 percent
- Q2 EPS was $0.65; adjusted1 EPS was $0.63
- Lowered second half underlying sales growth outlook to approximately 10 percent
- Expect strong double-digit adjusted EPS growth in the second half
- Repurchased $355 million of stock in Q2
Outlook
Primarily as a result of more pronounced FX headwinds and the slower than expected improvement in COVID-related hospital staffing, the company is lowering its guidance to more accurately reflect these challenges. The company expects approximately 10 percent underlying sales growth in the second half of the year. For total Edwards, the company now expects full year 2022 sales of $5.35 to $5.55 billion. For TAVR, $3.5 to $3.7 billion; for TMTT, $110 to $140 million; for Surgical Structural Heart, $870 to $950 million; and for Critical Care, $820 to $900 million. The company now expects full year adjusted EPS guidance at the bottom end of its original guidance range of $2.50 to $2.65, representing double-digit growth over 2021.
For the third quarter of 2022, the company projects total sales to be between $1.30 and $1.37 billion, and adjusted EPS of $0.58 to $0.66.
"Our strong foundation of technology leadership, combined with a robust pipeline, positions us well for continued success," said Mussallem. "As patients and clinicians increasingly recognize the significant benefits of transcatheter-based technologies, supported by the substantial body of compelling evidence, we remain as optimistic as ever about the long-term growth opportunities."